Abstract P3-06-15: Evaluation of HER family protein signaling network as a predictive biomarker for pCR for breast cancer patients treated with neratinib in the I-SPY 2 trialJulia Wulfkuhle, Emanuel F. Petricoin, Ashish Sanil et al.|Cancer Research|2015Cited by 0
Abstract 4055: Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung cancer patients responding to atezolizumab treatmentMahesh Yadav, Evan W. Newell, Michael Fehlings et al.|Cancer Research|2019Cited by 0